A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
Clinical trial NCT02866747 · COMPLETED
Trial details
- NCT number
- NCT02866747
- Sponsor
- Institut Claudius Regaud
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-17
- Primary completion
- 2024-11-02
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.